LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000108 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 6, 2026 |
| Document | View SEC Filing |
Transactions
11
Total Shares
15,132
Total Value
$1,848,940.64
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLO & Secretary | Common Stock | โ | Jun 30, 2026 | Other Acquisition or Disposition | 132 | $160.71 | $21,213.65 | 41,514 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jul 1, 2026 | Exercise/Conversion | 5,000 | $52.27 | $261,350.00 | 46,514 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jul 1, 2026 | Sale | 396 | $308.99 | $122,359.49 | 46,118 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jul 1, 2026 | Sale | 104 | $310.20 | $32,261.04 | 46,014 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jul 1, 2026 | Sale | 1,119 | $311.72 | $348,814.68 | 44,895 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jul 1, 2026 | Sale | 1,081 | $312.28 | $337,572.95 | 43,814 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jul 1, 2026 | Sale | 700 | $313.46 | $219,420.18 | 43,114 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jul 1, 2026 | Sale | 100 | $314.58 | $31,457.88 | 43,014 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jul 1, 2026 | Sale | 900 | $315.78 | $284,199.75 | 42,114 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jul 1, 2026 | Sale | 600 | $317.15 | $190,291.02 | 41,514 | Direct | โ | View Details | |
CLO & Secretary | Employee Stock Option (right to buy) | Derivative | Jul 1, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 34,444 | Direct | โ | View Details |